File:A-Quantitative-Comparison-of-Human-HT-1080-Fibrosarcoma-Cells-and-Primary-Human-Dermal-Fibroblasts-pone.0081689.s012.ogv

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

A-Quantitative-Comparison-of-Human-HT-1080-Fibrosarcoma-Cells-and-Primary-Human-Dermal-Fibroblasts-pone.0081689.s012.ogv (Ogg Theora video file, length 4.8 s, 500 × 250 pixels, 458 kbps, file size: 268 KB)

Captions

Captions

Add a one-line explanation of what this file represents

Summary

[edit]
Description
English: Treatment with matrix metalloproteinase inhibitor (GM6001) blocks migration for HT-1080 fibrosarcoma cells in synthetic ECM. Time-lapse images (15 min / frame) illustrating HT-1080s migrating in synthetic ECM (220 Pa, 1000 μM CRGDS) after treatment with DMSO (control, left) or matrix metalloproteinase (MMP) inhibitor (GM6001, right). Images represent minimum intensity z-projections (middle 500 μm of ~1000 μm thick matrix). HT-1080s are shown for the same time frame used for tracking and quantification of motility. No HT-1080s moved more than one cell length after treatment with MMP-inhibitor, demonstrating that proteolysis is required for migration in synthetic ECM. Time shown in Hr:Min. Scale bar = 100 μm.
Date
Source Movie S1 from Schwartz M, Rogers R, Singh S, Lee J, Loveland S, Koepsel J, Witze E, Montanez-Sauri S, Sung K, Tokuda E, Sharma Y, Everhart L, Nguyen E, Zaman M, Beebe D, Ahn N, Murphy W, Anseth K (2013). "A Quantitative Comparison of Human HT-1080 Fibrosarcoma Cells and Primary Human Dermal Fibroblasts Identifies a 3D Migration Mechanism with Properties Unique to the Transformed Phenotype". PLOS ONE. DOI:10.1371/journal.pone.0081689. PMID 24349113. PMC: 3857815.
Author Schwartz M, Rogers R, Singh S, Lee J, Loveland S, Koepsel J, Witze E, Montanez-Sauri S, Sung K, Tokuda E, Sharma Y, Everhart L, Nguyen E, Zaman M, Beebe D, Ahn N, Murphy W, Anseth K
Permission
(Reusing this file)
w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 3.0 Unported license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
Provenance
InfoField
This file was transferred to Wikimedia Commons from PubMed Central by way of the Open Access Media Importer.
WikiProject Open Access
WikiProject Open Access

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current05:08, 20 December 20134.8 s, 500 × 250 (268 KB)Open Access Media Importer Bot (talk | contribs)Automatically uploaded media file from Open Access source. Please report problems or suggestions here.

There are no pages that use this file.

Transcode status

Update transcode status
Format Bitrate Download Status Encode time
VP9 240P 133 kbps Completed 21:43, 15 August 2018 2.0 s
WebM 360P 208 kbps Completed 12:48, 16 November 2023 1.0 s
QuickTime 144p (MJPEG) 341 kbps Completed 09:15, 14 October 2024 1.0 s

Metadata